Table 2

Comparison of gene amplification in tumours from patients with BRCA1 mutations and patients with breast cancer unselected for family history stratified by age

MarkerAge (years)BRCA1 mutation casesNon-familial controlsp Values
HER2 amplification data were captured only for samples that were previously identified as overexpressing HER2 protein.
p Values were determined using the two tailed Fisher's exact test.
ND, not determined.
CCND1<500/2017/480.002
≥500/102/261.0
HER2<500/213/170.09
≥501/10/0ND